Gliatech Halts Distribution Of Sole U.S. Product Following Supplier Recall
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials in support of premarket approval applications for Gliatech's Adcon-A and Adcon-P anti-adhesion solutions will go unaffected by the firm's decision to temporarily discontinue distribution of Adcon-L gel on account of a supplier recall. The recall also affects another gel formulation, Adcon-T/N.